| 000 | 01308 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516103145.0 | ||
| 264 | 0 | _c20120925 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a0003-3006 | ||
| 024 | 7 |
_a10.2344/0003-3006-59.2.90 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBecker, Daniel E | |
| 245 | 0 | 0 |
_aLocal anesthetics: review of pharmacological considerations. _h[electronic resource] |
| 260 |
_bAnesthesia progress _c2012 |
||
| 300 |
_a90-101; quiz 102-3 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xpharmacology |
| 650 | 0 | 4 | _aAnesthesia Recovery Period |
| 650 | 0 | 4 |
_aAnesthesia, Dental _xmethods |
| 650 | 0 | 4 | _aAnesthesia, Local |
| 650 | 0 | 4 |
_aAnesthetics, Local _xchemistry |
| 650 | 0 | 4 |
_aCarticaine _xpharmacology |
| 650 | 0 | 4 | _aDrug Hypersensitivity |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLidocaine _xpharmacology |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 |
_aPhentolamine _xpharmacology |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 700 | 1 | _aReed, Kenneth L | |
| 773 | 0 |
_tAnesthesia progress _gvol. 59 _gno. 2 _gp. 90-101; quiz 102-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2344/0003-3006-59.2.90 _zAvailable from publisher's website |
| 999 |
_c21966944 _d21966944 |
||